BRGTM - Technical Information
- Using Bio Regenerate’s proprietary method, the BRGTM cells are recovered from 450ml of un-mobilized peripheral blood.
- The method recovers 25-85x106 stem/progenitor cells.
- The cells in the recovered population express surface markers of hematopoietic, mesenchymal, endothelial and monocytic origin.
- The BRGTM cells can differentiate into endothelial and hematopoietic progenitor cells and express some characteristics of mesenchymal stem cells.
- In Vivo activity: The BRGTM cells were demonstrated to improve blood flow regeneration in a mouse limb ischemia model.


